Coeptis Therapeutics Holdings, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2020 to Q1 2024.
  • Coeptis Therapeutics Holdings, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.56M.
  • Coeptis Therapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4.92M, a 10.4% decline from 2022.
  • Coeptis Therapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $5.49M, a 33.2% decline from 2021.
  • Coeptis Therapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $8.22M, a 89.3% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.56M +$1.56M Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-08-16
Q1 2023 $0 -$1.13M -100% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-08-16
Q1 2022 $1.13M Jan 1, 2022 Mar 31, 2022 10-Q/A 2024-03-25
Q1 2020 $450* Jan 1, 2020 Mar 31, 2020 10-Q 2021-07-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.